Journal Article Summary
The article investigates a new type of ocular hydrogel designed to enhance the delivery of loratadine, a medication commonly used for allergic reactions. The study addresses the challenge of poor absorption and rapid drainage associated with traditional eye drops, which can lead to ineffective treatment. By developing a thermoresponsive hydrogel, the researchers aim to improve the drug's concentration and prolong its presence in the eye, potentially leading to better therapeutic outcomes for patients suffering from allergies.
To conduct the research, the authors created various formulations of loratadine-loaded hydrogels and tested their properties, including swelling, porosity, and drug release rates. They used a full-factorial design to evaluate eight different formulations, focusing on how the composition affected the hydrogels' characteristics. The results indicated that certain formulations significantly improved the permeability of loratadine through rabbit corneas, with some formulations showing up to 70 times greater drug permeation compared to a control solution. This suggests that the hydrogels could effectively enhance the delivery of loratadine to the eye.
However, the study has limitations, including the use of animal models, which may not fully replicate human responses. Additionally, while the hydrogels showed promising results in vitro, further research is needed to confirm their effectiveness and safety in actual clinical settings. Patients should consult with healthcare professionals about the potential benefits and risks of new drug delivery systems like these hydrogels, especially if they are considering alternative treatments for allergies or other eye-related conditions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Sharif Makhmalzadeh Behzad, Salimi Anayatollah, Niroomand Aida. Loratadine-Loaded Thermoresponsive Hydrogel: Characterization and Ex-vivo Rabbit Cornea Permeability Studies. Iranian Journal of Pharmaceutical Research : IJPR 2018. PMID: 29881404. PMCID: PMC5985164.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
